Participated · Equity · Nov 2025

OptimHire offers an end-to-end AI hiring platform featuring an AI Recruiter applicant-tracking system, outcome-based pricing in which businesses pay only for successful interviews, and Job Copilot, an AI assistant that autonomously searches and applies to jobs for candidates. The company claims its system enables clients to hire in an average of 12 days while cutting recruitment costs by up to 80%. In 2024, OptimHire filled more than 8,000 positions for companies such as Amazon, Google and Dropbox and expanded its candidate database to over 220 million professionals. Its risk-free pricing includes either a 6% flat recruitment fee or about $300 per month for a full-time AI recruiter. Recent partnerships with Monster, CareerBuilder and Nexxt extend the service across multiple industry verticals. Looking ahead, OptimHire plans to launch self-service hiring for SMBs and further automate its AI-to-AI hiring model to create a near-autonomous recruiting ecosystem. The company is funding this growth with a recently closed $6 million investment round.

Participated · Seed · Aug 2022

Ordaōs is a New York-based biotechnology company designing mini-proteins to help drug hunters deliver life-saving treatments. Led by CEO David Longo, the company positions itself as human-enabled and machine-driven, leveraging proprietary multitask meta-learning and reinforcement learning. Ordaōs uses the Ordaōs Design Engine to generate, appraise, and rank billions of protein sequences and hundreds of thousands of protein structures and properties to create customized miniPRO™ proteins. These proteins are rapidly evaluated in vitro to provide intelligent feedback on multiple design objectives, including structure, binding specificity and affinity, solubility, stability, immunogenicity, and developability. The iterative, continuous-learning process translates human-targeted product criteria into optimized mini-proteins intended to meet a client's molecular target product profile and enable targeted therapies that reduce patient suffering and extend life. The company raised $5M in Seed funding to support these efforts.

Participated · Series A · Jul 2022

Finwave Semiconductor develops transistors and differentiated GaN-on-Si RF chips designed to optimize the potential of Gallium Nitride (GaN). Its portfolio includes GaN FinFETs, advanced E-mode MISHEMTs, and high-performance RF switches. The company's chips target a wide array of RF applications, including communications infrastructure (base stations, MIMO, small cells, land mobile radios, customer premise equipment, fixed wireless access), Wi‑Fi routers, satellite, radar, drones, anti-drones, test & measurement equipment, and medical equipment. Led by CEO Dr. Pierre-Yves Lesaicherre and based in Waltham, MA, Finwave positions its technology across both infrastructure and mobile markets. The company recently raised funding to accelerate revenue generation, expand its product portfolio, and continue developing its GaN-on-Si technology. No operating metrics were disclosed in the article. Finwave Semiconductor is a Waltham, MA–based company that develops GaN transistors and 3DGaN technology for high‑frequency applications. Its 3DGaN technology and new transistor are designed to optimize Gallium Nitride (GaN) to support industries including 5G, AI, cloud computing, and electric and autonomous vehicles. Finwave says 3DGaN improves linearity, output power and efficiency in 5G mmWave systems while reducing costs for carriers. Founded in 2012 and led by CEO Dr. Bin Lu, the company has offices in Massachusetts and California and partners worldwide. The company raised $12.2M in a Series A and plans to use the proceeds to expand the team, product development activities and lab facilities.

Participated · Seed · Nov 2021

Zeit Medical offers a wearable early-warning system designed to monitor the brain during sleep and raise alarms if a stroke occurs. The device aims to get people to the hospital faster to mitigate stroke damage and potentially save lives. The company was founded in 2019 and is based in California. Zeit plans to use new funding to expand operations and build its team. It intends to apply for FDA approval for the device. The company has stated the device could be available as early as 2023.

Participated · Series A · Oct 2021

Openprise offers the Openprise RevOps Data Automation Cloud, a no-code platform that brings together data, automation, integration, and orchestration to unify siloed data and automate GTM processes. The flagship product is purpose-built for non-programmers and is marketed as enabling companies to scale GTM strategies at up to ten times the speed IT can support without writing code. Openprise positions itself to solve RevOps challenges such as poor data quality, fragmentation across point solutions, and unusable formats, and says it is helping customers prepare for AI-driven RevOps use cases. The company plans to use the new financing to extend its leadership in the RevOps market, expand its product roadmap, bolster talent recruitment, and invest in sales, marketing, GTM initiatives, and customer success programs. The announcement describes Openprise as having a strong balance sheet and impressive growth and notes enterprise customers across data-rich industries. The company is recognized in G2's 2023 Grid Reports and has been named a Great Place to Work by Inc. Magazine. Openprise provides a no-code RevOps Automation Platform that automates hundreds of sales and marketing processes. Led by founder and CEO Ed King, the platform handles tasks such as lead-to-account matching, lead routing, attribution, and account scoring. Customers include UI Path, Vimeo, Zendesk, Okta, Nutanix, Freshworks, Splunk, and Zscaler. The company secured $16M in Series A financing and intends to use the funds to accelerate product development and scale the team. Openprise aims to help customers simplify their tech stacks, scale operations, and respond faster to changing marketing conditions. Openprise provides a Data Orchestration Platform that simplifies data management and connects SaaS applications via no-code automation. The platform uses bots to automate large, data-driven processes that involve heavy computation and complex business logic, enabling non-technical ops teams to build and manage workflows without IT. By offering an integrated solution, Openprise helps customers remove multiple point solutions, reduce tech-stack complexity, and improve the ROI of SaaS investments. The company is initially focused on marketing use cases and plans to expand into sales, HR, finance, and other SaaS-reliant areas. Openprise has established relationships with enterprise customers and reports growing traction across industries. Founder and CEO Ed King brings technical and product marketing experience and has positioned the company as an Alumni Ventures Group portfolio company.